Post-traumatic Stress Disorder, Stress Disorder, Post-Traumatic
Conditions
Keywords
PTSD
Brief summary
This is a randomized, controlled trial of adjunctive art therapy during cognitive processing therapy for PTSD.
Detailed description
The objective of this study is to examine the effects of art therapy with combat veterans who have PTSD and to measure if it reduces symptoms more than verbal Cognitive Processing Therapy (CPT) alone. This study will incorporate art processes and materials into an already established protocol of CPT in order to create a sense of safety for veterans in beginning therapy, and access the nonverbal parts of the trauma in order to process it. Art-making will be used to help veterans address trauma and integrate who they were before the trauma with who they are currently. It will assist in addressing the grief and loss caused by combat, and will be used as veterans begin building a worldview and self-concept that are not filled with trauma and war. It is hypothesized that the veterans who receive art therapy with CPT will show a significantly greater decrease in PTSD symptoms than those who receive only CPT.
Interventions
BEHAVIORALCognitive Processing therapy
8 sessions of standard CPT from CPT manual developed by Dr. S Resick, Monson & Chard (11/2010)
BEHAVIORALArt + CPT
8 sessions of individual therapy of mixes techniques Art + CPT 8 sessions of standard CPT (same 8 as in control group) from manual developed by Dr.s Resick, Monson & Chard (11/2010)
BEHAVIORALCPT + Art Therapy
Subjects to complete 8 sessions of standard Cognitive Processing Therapy from manual developed by Dr. S. Resick, Monson & Chard (1/2010) CPT + Art Therapy of mixed individual techniques
Sponsors
Hampton VA Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* PCL-M initial score \>= 50; * Both genders, * All ethnicities, * Veterans in treatment for PTSD,
Exclusion criteria
* No active substance use disorder, * No active suicidal or homicidal ideation, * No psychosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| PTSD Symptoms assessed by PCL-M score | 8-12 weeks | PTSD symptoms will be measured by PCL-M score |
| Depression Symptoms assessed by Beck Depression Inventory-II | 8-12 weeks | Beck Depression Inventory-II will be used to measure depression |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Treatment Satisfaction assessed by Likert scale | 8-12 weeks | Likert scale will be used to compare satisfaction with art and CPT conditions |
| Treatment completion assessed by dropout rate | 8-12 weeks | Compare dropout rate between experimental and control groups during treatment |
Countries
United States
Outcome results
None listed